Literature DB >> 28991599

Examination of a Nurse-led Community-based Education and Coaching Intervention for Coronary Heart Disease High-risk Individuals in China.

Yan-Jin Huang1, Monica Parry2, Ying Zeng3, Yan Luo4, Jing Yang5, Guo-Ping He6.   

Abstract

PURPOSE: Early detection and management of coronary heart disease (CHD) are embedded into many community health service and primary care practices in western countries. The Framingham CHD risk score has been used to predict CHD and mortality for nearly 20 years, and it has predicted CHD event risk accurately in multiethnic populations. The aim of this study was to access the effect of a 6-month community-based intervention on CHD risk in individuals at high risk.
METHODS: A randomized controlled trial of individuals with a high 10-year CHD risk were recruited from two communities in China. Individuals in the intervention group (n = 53) received a 3-month group education and a 3-month coaching session. Physical examination and self-report questionnaires were used to collect both pre- and postintervention data on blood pressure, glucose, cholesterol, body mass index, smoking, depression, and health-related quality of life (HRQoL).
RESULTS: A total of 102 participants (85.0%) completed the 6-month study. Compared with the usual care group, the intervention group had a 5 mmHg greater reduction in systolic blood pressure (t = 2.01, p = .047), larger declines in glucose (t = -2.49, p = .015), cholesterol (t = -2.44, p = .017), body mass index (t = -2.58, p = .011), and depression (t = -2.05, p = .043), and better reports of HRQoL (t = 3.36, p = .001). No significant group differences in smoking behaviors were reported.
CONCLUSION: A 6-month community-based intervention in a CHD high-risk population improved disease-related risk factors, depression, and HRQoL. Results provide preliminary evidence for primary prevention of cardiovascular disease risk in a community high-risk population.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  coronary heart disease; intervention study; primary prevention

Mesh:

Year:  2017        PMID: 28991599     DOI: 10.1016/j.anr.2017.07.004

Source DB:  PubMed          Journal:  Asian Nurs Res (Korean Soc Nurs Sci)        ISSN: 1976-1317            Impact factor:   2.085


  6 in total

1.  Determining the frequency and level of task-sharing for hypertension management in LMICs: A systematic review and meta-analysis.

Authors:  Oluwabunmi Ogungbe; Danielle Cazabon; Adefunke Ajenikoko; Panniyammakal Jeemon; Andrew E Moran; Yvonne Commodore-Mensah
Journal:  EClinicalMedicine       Date:  2022-04-15

2.  Task sharing with non-physician health-care workers for management of blood pressure in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  T N Anand; Linju Maria Joseph; A V Geetha; Dorairaj Prabhakaran; Panniyammakal Jeemon
Journal:  Lancet Glob Health       Date:  2019-06       Impact factor: 38.927

Review 3.  Does a Nurse-Led Program of Support and Lifestyle Management for patients with coronary artery disease significantly improve psychological outcomes among the patients?: A meta-analysis.

Authors:  Zu-Chun Luo; Lu Zhai; Xia Dai
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

4.  The effect of self-management intervention program on the lifestyle of postmyocardial infarction patients.

Authors:  Roya Amini; Maryam Rajabi; Hiva Azami; Alireza Soltanian
Journal:  J Educ Health Promot       Date:  2021-05-20

5.  Contradictions between DAPT and PRECISE-DAPT scores with the severity of coronary lesion in acute coronary syndrome.

Authors:  Sisi Bi; Yue Zhao; Qingling Peng; Wenxue Liu; Guogang Zhang; Chenglong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

6.  Task-sharing interventions for improving control of diabetes in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Joseph Linju Maria; T N Anand; Boban Dona; Jose Prinu; Dorairaj Prabhakaran; Panniyammakal Jeemon
Journal:  Lancet Glob Health       Date:  2020-11-23       Impact factor: 26.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.